API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
91
PharmaCompass offers a list of Ethanol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ethanol manufacturer or Ethanol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethanol manufacturer or Ethanol supplier.
PharmaCompass also assists you with knowing the Ethanol API Price utilized in the formulation of products. Ethanol API Price is not always fixed or binding as the Ethanol Price is obtained through a variety of data sources. The Ethanol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 02884_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 02884_FLUKA, including repackagers and relabelers. The FDA regulates 02884_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 02884_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 02884_FLUKA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 02884_FLUKA supplier is an individual or a company that provides 02884_FLUKA active pharmaceutical ingredient (API) or 02884_FLUKA finished formulations upon request. The 02884_FLUKA suppliers may include 02884_FLUKA API manufacturers, exporters, distributors and traders.
click here to find a list of 02884_FLUKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 02884_FLUKA DMF (Drug Master File) is a document detailing the whole manufacturing process of 02884_FLUKA active pharmaceutical ingredient (API) in detail. Different forms of 02884_FLUKA DMFs exist exist since differing nations have different regulations, such as 02884_FLUKA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 02884_FLUKA DMF submitted to regulatory agencies in the US is known as a USDMF. 02884_FLUKA USDMF includes data on 02884_FLUKA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 02884_FLUKA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 02884_FLUKA suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 02884_FLUKA Drug Master File in Japan (02884_FLUKA JDMF) empowers 02884_FLUKA API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 02884_FLUKA JDMF during the approval evaluation for pharmaceutical products. At the time of 02884_FLUKA JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 02884_FLUKA suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 02884_FLUKA Drug Master File in Korea (02884_FLUKA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 02884_FLUKA. The MFDS reviews the 02884_FLUKA KDMF as part of the drug registration process and uses the information provided in the 02884_FLUKA KDMF to evaluate the safety and efficacy of the drug.
After submitting a 02884_FLUKA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 02884_FLUKA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 02884_FLUKA suppliers with KDMF on PharmaCompass.
A 02884_FLUKA CEP of the European Pharmacopoeia monograph is often referred to as a 02884_FLUKA Certificate of Suitability (COS). The purpose of a 02884_FLUKA CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 02884_FLUKA EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 02884_FLUKA to their clients by showing that a 02884_FLUKA CEP has been issued for it. The manufacturer submits a 02884_FLUKA CEP (COS) as part of the market authorization procedure, and it takes on the role of a 02884_FLUKA CEP holder for the record. Additionally, the data presented in the 02884_FLUKA CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 02884_FLUKA DMF.
A 02884_FLUKA CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 02884_FLUKA CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 02884_FLUKA suppliers with CEP (COS) on PharmaCompass.
02884_FLUKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 02884_FLUKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 02884_FLUKA GMP manufacturer or 02884_FLUKA GMP API supplier for your needs.
A 02884_FLUKA CoA (Certificate of Analysis) is a formal document that attests to 02884_FLUKA's compliance with 02884_FLUKA specifications and serves as a tool for batch-level quality control.
02884_FLUKA CoA mostly includes findings from lab analyses of a specific batch. For each 02884_FLUKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
02884_FLUKA may be tested according to a variety of international standards, such as European Pharmacopoeia (02884_FLUKA EP), 02884_FLUKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (02884_FLUKA USP).